These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 2818723)

  • 1. The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation.
    Geffin GA; Love TR; Hendren WG; Torchiana DF; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1989 Aug; 98(2):239-50. PubMed ID: 2818723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-induced ventricular contraction during cardioplegic arrest.
    Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
    Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
    Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts.
    Tian G; Biro GP; Butler KW; Xiang B; Vu C; Deslauriers R
    J Heart Lung Transplant; 1993; 12(1 Pt 1):81-8. PubMed ID: 8443206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of myocardial protection to cardioplegic solution pH: modulation by calcium and magnesium.
    Geffin GA; Reynolds TR; Titus JS; O'Keefe DD; Daggett WM
    Ann Thorac Surg; 1991 Oct; 52(4):955-64. PubMed ID: 1929661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
    Magovern JA; Pae WE; Miller CA; Waldhausen JA
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
    Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest.
    Ogino H; Smolenski RT; Zych M; Seymour AM; Yacoub MH
    Ann Thorac Surg; 1996 Aug; 62(2):469-74. PubMed ID: 8694607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
    de Wit L; Coetzee A; Kotze J; Lochner A
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
    Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
    J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution. Improved function, metabolism, and ultrastructure.
    Choong YS; Gavin JB; Buckman J
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):210-8. PubMed ID: 1735986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart preservation: analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a biochemical, ultrastructural, functional study.
    Sultan I; Sunamori M; Suzuki A
    J Heart Lung Transplant; 1992; 11(4 Pt 1):607-18. PubMed ID: 1379828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial preservation related to magnesium content of hyperkalemic cardioplegic solutions at 8 degrees C.
    Reynolds TR; Geffin GA; Titus JS; O'Keefe DD; Daggett WM
    Ann Thorac Surg; 1989 Jun; 47(6):907-13. PubMed ID: 2757448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
    Choong YS; Gavin JB
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
    Ina H; Yasuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.